Consequently, an increasing meropenem plasma concentration in the high-dose group might assumingly have an increasing trend in meropenem concentration in ELF, which was a target site in almost half of the patients in our study.
← all excerpts
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial.
1
—
—